CheckMyRecalls

JB Chemicals and Pharmaceuticals Ltd recalls Cetirizine Hydrochloride…

JB Chemicals and Pharmaceuticals Ltd recalls Cetirizine Hydrochloride Tablets USP 5 mg

Published
29 Jul 2026
Units affected
34,020 100-count bottles.
Agency
FDA
Country
United States

The hazard

Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.

Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-401-10.

Brand / company
JB Chemicals and Pharmaceuticals Ltd
Codes / lots
Lots: GY825029, GY825030, GY825031, GY825032, expires: 2028-OCT
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 29 Jul 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.